Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

NCT02691247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

BIOLOGICAL: CLBS03 Low Dose
BIOLOGICAL: CLBS03 High Dose
BIOLOGICAL: Placebo

Sponsor

Lisata Therapeutics, Inc.

Collaborators

[object Object]
[object Object]